Plerixafor, 10 years after approval: Time to abandon chemotherapy for stem cell mobilization?

Sanofi Genzyme supported Industry Lunch Symposium (Hall A)

Saturday, October 26


Chair: Nicolaus Kröger (Hamburg, Germany)
Welcome and introduction
Nicolaus Kröger (Hamburg, Germany)
Chemotherapy-based approaches
Nina Worel (Wien, Austria)
Cytokine-based approaches (including paediatric indications)
Mohamad Mohty (Paris, France)
Panel discussion

© The International Congress on Controversies in Stem Cell and Cellular Therapies (COSTEM).

Tel: +44 20 3289 9552